SecBot SecBot
8-K ·Filed Aug 7, 2026

ETST

Earth Science Tech, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC0001493152-26-036483
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

Monitor the upcoming annual meeting on August 31, 2026, where proposed Series B preferred cancellation and potential exchange uplisting will be discussed. Sustained profitability and cash flow generation support a possible valuation re-rating if the company uplists.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d
ETST ▼ -8.07% at T+20d
NEUTRAL call -8.07% · α vs SPY -7.67% · entry $0.0979 → $0.0900
Next anchor: T+60d in 5d
Latest observation: T+54 +56.01% FF3 residual α
Entry = T+0 close
Aug 7, 2026
via day close
T+1d
-6.84%
call -6.84% · α -6.81%
$0.0912
settled 3mo ago
T+5d
-8.07%
call -8.07% · α -8.47%
$0.0900
settled 3mo ago
T+20d
-8.07%
call -8.07% · α -7.67%
$0.0900
settled 8w ago
T+60d
Pending
in 5d

Price Chart

Loading chart...

Executive Summary

Earth Science Tech reported Q1 FY2027 revenue of $9.0M (+3% YoY) and net income of $715,697 (+57% YoY), with diluted EPS tripling to $0.003. Operating cash flow surged 108% to $707,131, and the company repurchased 3.7M shares. All key subsidiaries remained profitable.

Key Financial Metrics

EPS
$0.00
Revenue
$9.0M
+2.3% YoY
Rating
in line
Gross Margin
70%

Key Facts

  • Revenue $9.0M vs $8.8M in prior-year quarter (+3%)
  • Net income $715,697 vs $456,714 (+57%)
  • Diluted EPS $0.003 vs $0.001 (tripled YoY)
  • Operating cash flow $707,131 vs $339,376 (+108%)
  • Repurchased and retired 3.7M shares of common stock
  • All key operating subsidiaries profitable
  • Total assets $10.4M vs $7.8M a year ago

Financial Impact

Revenue growth of 3% YoY, net income growth of 57%, operating cash flow growth of 108%

revenuenet incomeepsoperating cash flow

Risk Factors

  • OTC-traded stock with limited liquidity and institutional coverage
  • Modest revenue growth (3%) may not support a high multiple
  • No forward guidance provided; execution risk on scaling pharmacy and telehealth platforms

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-036483
Exhibit: ex99-1.htm0001493152-26-036483
Document: 0001493152-26-036483-index-headers.html0001493152-26-036483
Document: 0001493152-26-036483-index.html0001493152-26-036483
Document: 0001493152-26-036483.txt0001493152-26-036483
8-K Data (Synthetic)0001493152-26-036483
6 reports for ETST
Performance horizon
Filters
Rows
Reports for ETST — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
8-K
NEUTRAL ★ 3/10
$0.0899awaiting T+20—$0.0947 (+5.34%)
Sep 1, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$0.0880 $0.0911▲ +3.52%▲ +2.34%$0.0947 (+7.61%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$0.1070 $0.0900▼ −15.89%▼ −14.37%$0.0947 (−11.50%)
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$0.0921 $0.0900▼ −2.28%▼ −0.53%$0.0947 (+2.82%)
Aug 7, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$0.0979 $0.0900▼ −8.07%▼ −7.67%$0.0947 (−3.27%)
Jun 18, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$0.1760 $0.1400▼ −20.45%▼ −19.99%$0.0947 (−46.19%)
Showing 6 of 6

US Market Status

Market Closed — Opens Thu (11h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 7, 2026